Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.99707904 |
2 | axon ensheathment in central nervous system (GO:0032291) | 4.15873270 |
3 | central nervous system myelination (GO:0022010) | 4.15873270 |
4 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.90924864 |
5 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87050782 |
6 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.84949653 |
7 | fatty acid elongation (GO:0030497) | 3.62121981 |
8 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.54186776 |
9 | focal adhesion assembly (GO:0048041) | 3.49882136 |
10 | cell-substrate adherens junction assembly (GO:0007045) | 3.49882136 |
11 | mannose metabolic process (GO:0006013) | 3.46453290 |
12 | apoptotic process involved in morphogenesis (GO:0060561) | 3.45486865 |
13 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.43195125 |
14 | acyl-CoA biosynthetic process (GO:0071616) | 3.39467562 |
15 | thioester biosynthetic process (GO:0035384) | 3.39467562 |
16 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.39355965 |
17 | embryonic process involved in female pregnancy (GO:0060136) | 3.39321189 |
18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37246197 |
19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37246197 |
20 | modulation by symbiont of host immune response (GO:0052553) | 3.37246197 |
21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37246197 |
22 | modulation by symbiont of host defense response (GO:0052031) | 3.37246197 |
23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37246197 |
24 | proline biosynthetic process (GO:0006561) | 3.36080795 |
25 | pentose-phosphate shunt (GO:0006098) | 3.32329769 |
26 | adherens junction assembly (GO:0034333) | 3.31153140 |
27 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.29541288 |
28 | very long-chain fatty acid metabolic process (GO:0000038) | 3.22383493 |
29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.22156519 |
30 | L-phenylalanine catabolic process (GO:0006559) | 3.22156519 |
31 | surfactant homeostasis (GO:0043129) | 3.22016782 |
32 | ethanol oxidation (GO:0006069) | 3.20269810 |
33 | response to muramyl dipeptide (GO:0032495) | 3.19156960 |
34 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.18515976 |
35 | myelin maintenance (GO:0043217) | 3.17549581 |
36 | response to laminar fluid shear stress (GO:0034616) | 3.15938257 |
37 | response to peptidoglycan (GO:0032494) | 3.15692849 |
38 | creatine metabolic process (GO:0006600) | 3.15677462 |
39 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.14081337 |
40 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.13412653 |
41 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.10431147 |
42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.10337438 |
43 | L-phenylalanine metabolic process (GO:0006558) | 3.10337438 |
44 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.05945081 |
45 | maternal placenta development (GO:0001893) | 3.05653849 |
46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.02681163 |
47 | regulation of chromatin binding (GO:0035561) | 3.01911763 |
48 | regulation of early endosome to late endosome transport (GO:2000641) | 3.00122532 |
49 | regulation of cholesterol metabolic process (GO:0090181) | 2.99015309 |
50 | glycine transport (GO:0015816) | 2.96340373 |
51 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.95772085 |
52 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.95134260 |
53 | RNA stabilization (GO:0043489) | 2.93019753 |
54 | mRNA stabilization (GO:0048255) | 2.93019753 |
55 | low-density lipoprotein particle clearance (GO:0034383) | 2.91063095 |
56 | cellular protein complex localization (GO:0034629) | 2.89468210 |
57 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.87542426 |
58 | protein complex localization (GO:0031503) | 2.87410803 |
59 | positive regulation of macrophage cytokine production (GO:0060907) | 2.86137223 |
60 | cholesterol catabolic process (GO:0006707) | 2.85877619 |
61 | sterol catabolic process (GO:0016127) | 2.85877619 |
62 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.85680321 |
63 | positive regulation of myotube differentiation (GO:0010831) | 2.85627608 |
64 | regulation of beta-amyloid formation (GO:1902003) | 2.85042102 |
65 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.84407038 |
66 | NADPH regeneration (GO:0006740) | 2.84320667 |
67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.84249701 |
68 | response to methylmercury (GO:0051597) | 2.83522059 |
69 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.82989140 |
70 | regulation of cholesterol homeostasis (GO:2000188) | 2.82671502 |
71 | potassium ion import (GO:0010107) | 2.82597025 |
72 | cellular response to cholesterol (GO:0071397) | 2.80173930 |
73 | aspartate family amino acid catabolic process (GO:0009068) | 2.78390235 |
74 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.76158019 |
75 | NADH metabolic process (GO:0006734) | 2.73114097 |
76 | activation of Rac GTPase activity (GO:0032863) | 2.71008927 |
77 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.67458311 |
78 | regulation of ARF protein signal transduction (GO:0032012) | 2.67259520 |
79 | positive thymic T cell selection (GO:0045059) | 2.66912372 |
80 | activation of MAPKKK activity (GO:0000185) | 2.66290575 |
81 | dicarboxylic acid catabolic process (GO:0043649) | 2.66042336 |
82 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.65760793 |
83 | histone H3-K36 demethylation (GO:0070544) | 2.64151627 |
84 | sodium ion export (GO:0071436) | 2.63948491 |
85 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.63012838 |
86 | cellular hyperosmotic response (GO:0071474) | 2.61780555 |
87 | positive regulation of protein dephosphorylation (GO:0035307) | 2.60975457 |
88 | stress fiber assembly (GO:0043149) | 2.60339224 |
89 | modulation by virus of host process (GO:0019054) | 2.60220957 |
90 | glucose catabolic process (GO:0006007) | 2.57880997 |
91 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.57856183 |
92 | positive regulation of histone deacetylation (GO:0031065) | 2.55707221 |
93 | ethanol metabolic process (GO:0006067) | 2.55119557 |
94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.53611573 |
95 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.53412340 |
96 | regulation of macrophage cytokine production (GO:0010935) | 2.53294125 |
97 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.53262087 |
98 | negative regulation of myotube differentiation (GO:0010832) | 2.52694848 |
99 | sulfur amino acid catabolic process (GO:0000098) | 2.52679277 |
100 | modulation by symbiont of host cellular process (GO:0044068) | 2.51504589 |
101 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51290733 |
102 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.51248138 |
103 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.51173470 |
104 | detection of other organism (GO:0098543) | 2.51087464 |
105 | acetyl-CoA metabolic process (GO:0006084) | 2.50320661 |
106 | regulation of translational fidelity (GO:0006450) | 2.50312418 |
107 | DNA unwinding involved in DNA replication (GO:0006268) | 2.49622830 |
108 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.49183508 |
109 | cellular potassium ion homeostasis (GO:0030007) | 2.48974693 |
110 | short-chain fatty acid metabolic process (GO:0046459) | 2.47502276 |
111 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.46972125 |
112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46766400 |
113 | negative regulation of necroptotic process (GO:0060546) | 2.46756925 |
114 | chemical homeostasis within a tissue (GO:0048875) | 2.46746299 |
115 | glucose 6-phosphate metabolic process (GO:0051156) | 2.45623773 |
116 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.44794816 |
117 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.44794816 |
118 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43887923 |
119 | cell communication by electrical coupling (GO:0010644) | 2.43653920 |
120 | fatty acid beta-oxidation (GO:0006635) | 2.43370021 |
121 | negative regulation of cell size (GO:0045792) | 2.43329930 |
122 | regulation of response to osmotic stress (GO:0047484) | 2.42905819 |
123 | detection of bacterium (GO:0016045) | 2.40651675 |
124 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.40509006 |
125 | negative regulation of cell killing (GO:0031342) | 2.40509006 |
126 | regulation of lipoprotein metabolic process (GO:0050746) | 2.40438662 |
127 | acyl-CoA metabolic process (GO:0006637) | 2.40192295 |
128 | thioester metabolic process (GO:0035383) | 2.40192295 |
129 | ensheathment of neurons (GO:0007272) | 2.39657144 |
130 | axon ensheathment (GO:0008366) | 2.39657144 |
131 | barbed-end actin filament capping (GO:0051016) | 2.38252654 |
132 | low-density lipoprotein particle remodeling (GO:0034374) | 2.37794272 |
133 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.37487667 |
134 | thymic T cell selection (GO:0045061) | 2.36674539 |
135 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.35760214 |
136 | myelination (GO:0042552) | 2.35385014 |
137 | cellular modified amino acid catabolic process (GO:0042219) | 2.35303280 |
138 | regulation of autophagic vacuole assembly (GO:2000785) | 2.34184606 |
139 | cell communication involved in cardiac conduction (GO:0086065) | 2.34167092 |
140 | reverse cholesterol transport (GO:0043691) | 2.33731580 |
141 | macrophage activation involved in immune response (GO:0002281) | 2.33573672 |
142 | tricarboxylic acid metabolic process (GO:0072350) | 2.33100009 |
143 | fatty acid homeostasis (GO:0055089) | 2.32479071 |
144 | triglyceride biosynthetic process (GO:0019432) | 2.32460623 |
145 | fatty acid catabolic process (GO:0009062) | 2.30651855 |
146 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.30558472 |
147 | coenzyme catabolic process (GO:0009109) | 2.30358146 |
148 | cholesterol biosynthetic process (GO:0006695) | 2.30193367 |
149 | proline metabolic process (GO:0006560) | 2.29876793 |
150 | response to dietary excess (GO:0002021) | 2.29768659 |
151 | cellular response to sterol (GO:0036315) | 2.29585851 |
152 | macroautophagy (GO:0016236) | 2.29176130 |
153 | cysteine metabolic process (GO:0006534) | 2.28811290 |
154 | regulation of membrane repolarization (GO:0060306) | 2.28661386 |
155 | regulation of necrotic cell death (GO:0010939) | 2.28292452 |
156 | alanine transport (GO:0032328) | 2.28247394 |
157 | regulation of cholesterol esterification (GO:0010872) | 2.27168847 |
158 | protein localization to endosome (GO:0036010) | 2.26904553 |
159 | acylglycerol biosynthetic process (GO:0046463) | 2.26727442 |
160 | neutral lipid biosynthetic process (GO:0046460) | 2.26727442 |
161 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.26339387 |
162 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.25831784 |
163 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.25762054 |
164 | mitochondrial DNA metabolic process (GO:0032042) | 2.25660572 |
165 | modulation by virus of host morphology or physiology (GO:0019048) | 2.25511981 |
166 | regulation of gamma-delta T cell activation (GO:0046643) | 2.24729746 |
167 | negative regulation of protein localization to cell surface (GO:2000009) | 2.23920575 |
168 | monosaccharide biosynthetic process (GO:0046364) | 2.23712412 |
169 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.22579881 |
170 | response to mercury ion (GO:0046689) | 2.22389741 |
171 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22053587 |
172 | membrane repolarization (GO:0086009) | 2.22013709 |
173 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.21263939 |
174 | establishment of mitochondrion localization (GO:0051654) | 2.21117542 |
175 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.21083432 |
176 | cell-substrate junction assembly (GO:0007044) | 2.20982108 |
177 | lipid oxidation (GO:0034440) | 2.20177973 |
178 | skeletal muscle contraction (GO:0003009) | 2.18498784 |
179 | high-density lipoprotein particle remodeling (GO:0034375) | 2.18492735 |
180 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.17673320 |
181 | heterochromatin organization (GO:0070828) | 2.17298819 |
182 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.16973875 |
183 | oligodendrocyte differentiation (GO:0048709) | 2.16554858 |
184 | glutamate metabolic process (GO:0006536) | 2.16388752 |
185 | fatty acid oxidation (GO:0019395) | 2.14954112 |
186 | L-serine transport (GO:0015825) | 2.14761365 |
187 | detection of temperature stimulus (GO:0016048) | 2.14041218 |
188 | linoleic acid metabolic process (GO:0043651) | 2.13595914 |
189 | protein-lipid complex assembly (GO:0065005) | 2.13292868 |
190 | plasma lipoprotein particle clearance (GO:0034381) | 2.12454622 |
191 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.12166441 |
192 | monocarboxylic acid catabolic process (GO:0072329) | 2.12042984 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.27061745 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61833749 |
3 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.41789801 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.28261761 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.95255692 |
6 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.73057090 |
7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.60497223 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.59892808 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58991149 |
10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.51481917 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42655842 |
12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.36584278 |
13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.30919252 |
14 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23857485 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19042602 |
16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09130942 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01667411 |
18 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.97785119 |
19 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84769257 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82539713 |
21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.81965100 |
22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.81776407 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81228884 |
24 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.80760683 |
25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.78980315 |
26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.78852773 |
27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75773433 |
28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.74885190 |
29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70235258 |
30 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.64906424 |
31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62489174 |
32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.62388809 |
33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58732569 |
34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58403503 |
35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57653987 |
36 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.53473833 |
37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51744584 |
38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50713850 |
39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50088801 |
40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49155128 |
41 | MAF_26560356_Chip-Seq_TH2_Human | 1.48820501 |
42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.44206251 |
43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41234892 |
44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41172613 |
45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40557373 |
46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40295237 |
47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39480151 |
48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39065846 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38983168 |
50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38977730 |
51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38045849 |
52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37251209 |
53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36798551 |
54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36607429 |
55 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36558880 |
56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36558880 |
57 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36460693 |
58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36087249 |
59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35686679 |
60 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.34657530 |
61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34470286 |
62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34106375 |
63 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34045290 |
64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32973438 |
65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32885357 |
66 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32661464 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32507830 |
68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.32376384 |
69 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32074325 |
70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27590523 |
71 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.27435131 |
72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27023289 |
73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26109144 |
74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26037889 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25552495 |
76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25490283 |
77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24614135 |
78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24614135 |
79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24366023 |
80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21413654 |
81 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20630443 |
82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20125511 |
83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19864411 |
84 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19855544 |
85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19117462 |
86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18204398 |
87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17483855 |
88 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17459951 |
89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17380792 |
90 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14374440 |
91 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13872072 |
92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13863195 |
93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13657849 |
94 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11390166 |
95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11212470 |
96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10734856 |
97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10571677 |
98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10210265 |
99 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09896605 |
100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09608834 |
101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08482853 |
102 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.07161146 |
103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06125489 |
104 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06100720 |
105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06048490 |
106 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05842677 |
107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05744708 |
108 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05131734 |
109 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04864321 |
110 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03641270 |
111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03363206 |
112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03210543 |
113 | P68_20966046_ChIP-Seq_HELA_Human | 1.02852138 |
114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02439326 |
115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01887037 |
116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01203765 |
117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01045659 |
118 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00988935 |
119 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00842286 |
120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99964773 |
121 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99917570 |
122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99290117 |
123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99100045 |
124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97452858 |
125 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97444858 |
126 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97359713 |
127 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97329695 |
128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96791880 |
129 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96008437 |
130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95862764 |
131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95073637 |
132 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94503673 |
133 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93665061 |
134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93583192 |
135 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.93540985 |
136 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93348159 |
137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92755874 |
138 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92627042 |
139 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.92499020 |
140 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92012313 |
141 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91396114 |
142 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90369610 |
143 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90278086 |
144 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90264430 |
145 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.89769516 |
146 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89628179 |
147 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89239684 |
148 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89231691 |
149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88925285 |
150 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88883875 |
151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88793950 |
152 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88038511 |
153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87868508 |
154 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86246597 |
155 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.86089290 |
156 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.85883554 |
157 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85653875 |
158 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.84279191 |
159 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.83811368 |
160 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83288654 |
161 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83069401 |
162 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.82750709 |
163 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.81727744 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009840_abnormal_foam_cell | 3.86662038 |
2 | MP0005451_abnormal_body_composition | 3.69764864 |
3 | MP0003329_amyloid_beta_deposits | 3.60273964 |
4 | MP0005083_abnormal_biliary_tract | 3.14648112 |
5 | MP0005076_abnormal_cell_differentiation | 3.06452699 |
6 | MP0002139_abnormal_hepatobiliary_system | 2.95378698 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 2.89113620 |
8 | MP0009278_abnormal_bone_marrow | 2.66869505 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.45965950 |
10 | MP0003303_peritoneal_inflammation | 2.44648990 |
11 | MP0003690_abnormal_glial_cell | 2.34459387 |
12 | MP0000604_amyloidosis | 2.32651787 |
13 | MP0005058_abnormal_lysosome_morphology | 2.27241591 |
14 | MP0000751_myopathy | 2.26242628 |
15 | MP0004233_abnormal_muscle_weight | 2.25898098 |
16 | MP0004858_abnormal_nervous_system | 2.21362603 |
17 | MP0003436_decreased_susceptibility_to | 2.19107194 |
18 | MP0000920_abnormal_myelination | 2.18212858 |
19 | MP0008260_abnormal_autophagy | 2.11344276 |
20 | MP0005085_abnormal_gallbladder_physiolo | 2.06595369 |
21 | MP0002909_abnormal_adrenal_gland | 2.03001005 |
22 | MP0001849_ear_inflammation | 2.01277934 |
23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.00633453 |
24 | MP0009672_abnormal_birth_weight | 1.99870258 |
25 | MP0005365_abnormal_bile_salt | 1.95875242 |
26 | MP0004270_analgesia | 1.91045611 |
27 | MP0004036_abnormal_muscle_relaxation | 1.84802491 |
28 | MP0004782_abnormal_surfactant_physiolog | 1.82304447 |
29 | MP0000749_muscle_degeneration | 1.75407293 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.70167772 |
31 | MP0003075_altered_response_to | 1.67645054 |
32 | MP0005360_urolithiasis | 1.66170513 |
33 | MP0003634_abnormal_glial_cell | 1.63797288 |
34 | MP0001958_emphysema | 1.63591580 |
35 | MP0004130_abnormal_muscle_cell | 1.61597153 |
36 | MP0010329_abnormal_lipoprotein_level | 1.60911314 |
37 | MP0000747_muscle_weakness | 1.60644634 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.59462868 |
39 | MP0002249_abnormal_larynx_morphology | 1.59395367 |
40 | MP0003453_abnormal_keratinocyte_physiol | 1.57860203 |
41 | MP0004947_skin_inflammation | 1.56515138 |
42 | MP0002009_preneoplasia | 1.53885344 |
43 | MP0000750_abnormal_muscle_regeneration | 1.50889897 |
44 | MP0003195_calcinosis | 1.50352637 |
45 | MP0005332_abnormal_amino_acid | 1.49738307 |
46 | MP0004084_abnormal_cardiac_muscle | 1.49285162 |
47 | MP0000685_abnormal_immune_system | 1.47285740 |
48 | MP0002733_abnormal_thermal_nociception | 1.46123203 |
49 | MP0005167_abnormal_blood-brain_barrier | 1.45590488 |
50 | MP0004043_abnormal_pH_regulation | 1.45448289 |
51 | MP0004885_abnormal_endolymph | 1.43659676 |
52 | MP0000678_abnormal_parathyroid_gland | 1.42969583 |
53 | MP0003656_abnormal_erythrocyte_physiolo | 1.42098457 |
54 | MP0002396_abnormal_hematopoietic_system | 1.41414652 |
55 | MP0000013_abnormal_adipose_tissue | 1.40176510 |
56 | MP0003633_abnormal_nervous_system | 1.35082559 |
57 | MP0010630_abnormal_cardiac_muscle | 1.32326841 |
58 | MP0003828_pulmonary_edema | 1.31729165 |
59 | MP0002877_abnormal_melanocyte_morpholog | 1.30288448 |
60 | MP0003950_abnormal_plasma_membrane | 1.28462651 |
61 | MP0003091_abnormal_cell_migration | 1.28406495 |
62 | MP0004215_abnormal_myocardial_fiber | 1.27929124 |
63 | MP0002971_abnormal_brown_adipose | 1.26344838 |
64 | MP0010234_abnormal_vibrissa_follicle | 1.24242045 |
65 | MP0002419_abnormal_innate_immunity | 1.23201000 |
66 | MP0009780_abnormal_chondrocyte_physiolo | 1.22108485 |
67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21758944 |
68 | MP0000858_altered_metastatic_potential | 1.20259056 |
69 | MP0000733_abnormal_muscle_development | 1.19434108 |
70 | MP0003137_abnormal_impulse_conducting | 1.19002072 |
71 | MP0005330_cardiomyopathy | 1.18375219 |
72 | MP0002735_abnormal_chemical_nociception | 1.16552214 |
73 | MP0004808_abnormal_hematopoietic_stem | 1.16317844 |
74 | MP0002089_abnormal_postnatal_growth/wei | 1.15894226 |
75 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15798944 |
76 | MP0003646_muscle_fatigue | 1.13938732 |
77 | MP0003183_abnormal_peptide_metabolism | 1.13314708 |
78 | MP0005623_abnormal_meninges_morphology | 1.13263709 |
79 | MP0001346_abnormal_lacrimal_gland | 1.12176241 |
80 | MP0004087_abnormal_muscle_fiber | 1.12103740 |
81 | MP0008004_abnormal_stomach_pH | 1.11644566 |
82 | MP0001970_abnormal_pain_threshold | 1.11076933 |
83 | MP0002972_abnormal_cardiac_muscle | 1.10221869 |
84 | MP0003631_nervous_system_phenotype | 1.09733676 |
85 | MP0002295_abnormal_pulmonary_circulatio | 1.09293838 |
86 | MP0002090_abnormal_vision | 1.08724825 |
87 | MP0001666_abnormal_nutrient_absorption | 1.08412505 |
88 | MP0001348_abnormal_lacrimal_gland | 1.06912401 |
89 | MP0002269_muscular_atrophy | 1.04876796 |
90 | MP0002132_abnormal_respiratory_system | 1.04652982 |
91 | MP0005165_increased_susceptibility_to | 1.04263344 |
92 | MP0005670_abnormal_white_adipose | 1.04260348 |
93 | MP0003763_abnormal_thymus_physiology | 1.02203266 |
94 | MP0004859_abnormal_synaptic_plasticity | 1.01473385 |
95 | MP0005025_abnormal_response_to | 1.01113571 |
96 | MP0003632_abnormal_nervous_system | 1.00845305 |
97 | MP0000003_abnormal_adipose_tissue | 1.00305631 |
98 | MP0000703_abnormal_thymus_morphology | 0.98796288 |
99 | MP0001730_embryonic_growth_arrest | 0.97895817 |
100 | MP0002796_impaired_skin_barrier | 0.97796808 |
101 | MP0003279_aneurysm | 0.97100824 |
102 | MP0009333_abnormal_splenocyte_physiolog | 0.95980261 |
103 | MP0002254_reproductive_system_inflammat | 0.95519445 |
104 | MP0003252_abnormal_bile_duct | 0.95219812 |
105 | MP0000343_altered_response_to | 0.93837203 |
106 | MP0008569_lethality_at_weaning | 0.93043830 |
107 | MP0004381_abnormal_hair_follicle | 0.92871591 |
108 | MP0002998_abnormal_bone_remodeling | 0.92696836 |
109 | MP0002272_abnormal_nervous_system | 0.92417429 |
110 | MP0002734_abnormal_mechanical_nocicepti | 0.92230126 |
111 | MP0000639_abnormal_adrenal_gland | 0.90526869 |
112 | MP0002229_neurodegeneration | 0.89899093 |
113 | MP0002398_abnormal_bone_marrow | 0.89611042 |
114 | MP0000350_abnormal_cell_proliferation | 0.88522981 |
115 | MP0001177_atelectasis | 0.88314308 |
116 | MP0005166_decreased_susceptibility_to | 0.88183919 |
117 | MP0003172_abnormal_lysosome_physiology | 0.87982813 |
118 | MP0005620_abnormal_muscle_contractility | 0.86873789 |
119 | MP0002106_abnormal_muscle_physiology | 0.86629480 |
120 | MP0003300_gastrointestinal_ulcer | 0.86382450 |
121 | MP0000490_abnormal_crypts_of | 0.86073825 |
122 | MP0002064_seizures | 0.85607275 |
123 | MP0004185_abnormal_adipocyte_glucose | 0.85441241 |
124 | MP0004145_abnormal_muscle_electrophysio | 0.85214759 |
125 | MP0005397_hematopoietic_system_phenotyp | 0.85028866 |
126 | MP0001545_abnormal_hematopoietic_system | 0.85028866 |
127 | MP0005000_abnormal_immune_tolerance | 0.84262289 |
128 | MP0005375_adipose_tissue_phenotype | 0.83857447 |
129 | MP0005621_abnormal_cell_physiology | 0.83593896 |
130 | MP0001968_abnormal_touch/_nociception | 0.81458855 |
131 | MP0009643_abnormal_urine_homeostasis | 0.81240728 |
132 | MP0002166_altered_tumor_susceptibility | 0.79328394 |
133 | MP0005387_immune_system_phenotype | 0.78789659 |
134 | MP0001790_abnormal_immune_system | 0.78789659 |
135 | MP0000579_abnormal_nail_morphology | 0.78527107 |
136 | MP0002420_abnormal_adaptive_immunity | 0.78204249 |
137 | MP0003111_abnormal_nucleus_morphology | 0.78184524 |
138 | MP0003635_abnormal_synaptic_transmissio | 0.77950407 |
139 | MP0001819_abnormal_immune_cell | 0.77927585 |
140 | MP0003705_abnormal_hypodermis_morpholog | 0.77803305 |
141 | MP0006138_congestive_heart_failure | 0.77617597 |
142 | MP0000609_abnormal_liver_physiology | 0.77267375 |
143 | MP0001544_abnormal_cardiovascular_syste | 0.76847353 |
144 | MP0005385_cardiovascular_system_phenoty | 0.76847353 |
145 | MP0002736_abnormal_nociception_after | 0.76841548 |
146 | MP0001533_abnormal_skeleton_physiology | 0.76519102 |
147 | MP0002078_abnormal_glucose_homeostasis | 0.76496787 |
148 | MP0006036_abnormal_mitochondrial_physio | 0.76113477 |
149 | MP0004510_myositis | 0.75679856 |
150 | MP0002722_abnormal_immune_system | 0.74460812 |
151 | MP0004142_abnormal_muscle_tone | 0.74341735 |
152 | MP0004085_abnormal_heartbeat | 0.74313694 |
153 | MP0001502_abnormal_circadian_rhythm | 0.73747927 |
154 | MP0001800_abnormal_humoral_immune | 0.71614791 |
155 | MP0004264_abnormal_extraembryonic_tissu | 0.71274396 |
156 | MP0002970_abnormal_white_adipose | 0.71193640 |
157 | MP0001664_abnormal_digestion | 0.71186427 |
158 | MP0001299_abnormal_eye_distance/ | 0.71172811 |
159 | MP0005388_respiratory_system_phenotype | 0.70877935 |
160 | MP0002133_abnormal_respiratory_system | 0.70877935 |
161 | MP0003566_abnormal_cell_adhesion | 0.70862018 |
162 | MP0003984_embryonic_growth_retardation | 0.70792505 |
163 | MP0005501_abnormal_skin_physiology | 0.70475128 |
164 | MP0005666_abnormal_adipose_tissue | 0.70471615 |
165 | MP0000759_abnormal_skeletal_muscle | 0.70088762 |
166 | MP0002080_prenatal_lethality | 0.69028464 |
167 | MP0005334_abnormal_fat_pad | 0.68670611 |
168 | MP0002723_abnormal_immune_serum | 0.68092622 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 5.33181998 |
2 | Cerebral inclusion bodies (HP:0100314) | 4.23641406 |
3 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.83518917 |
4 | Supranuclear gaze palsy (HP:0000605) | 3.60917802 |
5 | Megalencephaly (HP:0001355) | 3.59495964 |
6 | Myopathic facies (HP:0002058) | 3.42933952 |
7 | Hyperacusis (HP:0010780) | 3.42416179 |
8 | Xanthomatosis (HP:0000991) | 3.40121711 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.29127731 |
10 | Distal lower limb muscle weakness (HP:0009053) | 3.27350151 |
11 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.25454027 |
12 | Hyporeflexia of lower limbs (HP:0002600) | 3.12928632 |
13 | Muscle fiber inclusion bodies (HP:0100299) | 3.05386698 |
14 | Ketoacidosis (HP:0001993) | 3.03335778 |
15 | Obstructive sleep apnea (HP:0002870) | 2.99768937 |
16 | Late onset (HP:0003584) | 2.92849666 |
17 | Increased connective tissue (HP:0009025) | 2.92800474 |
18 | Type 1 muscle fiber predominance (HP:0003803) | 2.92482125 |
19 | Interstitial pulmonary disease (HP:0006530) | 2.90176184 |
20 | Nemaline bodies (HP:0003798) | 2.89628697 |
21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.86844153 |
22 | Hypoglycemic coma (HP:0001325) | 2.80004125 |
23 | Axonal loss (HP:0003447) | 2.78742731 |
24 | Sudden death (HP:0001699) | 2.76773965 |
25 | Myokymia (HP:0002411) | 2.75891785 |
26 | Eczematoid dermatitis (HP:0000976) | 2.74768160 |
27 | Pheochromocytoma (HP:0002666) | 2.71735352 |
28 | Ketosis (HP:0001946) | 2.70867148 |
29 | Deep venous thrombosis (HP:0002625) | 2.67558673 |
30 | Hyperlipoproteinemia (HP:0010980) | 2.61199051 |
31 | Cellulitis (HP:0100658) | 2.59185182 |
32 | Exercise-induced myalgia (HP:0003738) | 2.57816183 |
33 | Ulnar bowing (HP:0003031) | 2.57699782 |
34 | Abnormality of the fingertips (HP:0001211) | 2.54982867 |
35 | Muscle fiber splitting (HP:0003555) | 2.54447354 |
36 | Dysmetric saccades (HP:0000641) | 2.52133054 |
37 | Asymmetric septal hypertrophy (HP:0001670) | 2.51274015 |
38 | Myoglobinuria (HP:0002913) | 2.50001180 |
39 | Intrahepatic cholestasis (HP:0001406) | 2.46499027 |
40 | Insomnia (HP:0100785) | 2.45734892 |
41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.44140543 |
42 | Complement deficiency (HP:0004431) | 2.42228922 |
43 | Gout (HP:0001997) | 2.42222509 |
44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41549418 |
45 | Achilles tendon contracture (HP:0001771) | 2.41030227 |
46 | Distal lower limb amyotrophy (HP:0008944) | 2.40662511 |
47 | Cerebral hemorrhage (HP:0001342) | 2.39424754 |
48 | Action tremor (HP:0002345) | 2.38685275 |
49 | Progressive muscle weakness (HP:0003323) | 2.37985203 |
50 | Ankle clonus (HP:0011448) | 2.37638764 |
51 | Back pain (HP:0003418) | 2.35394862 |
52 | Neuroendocrine neoplasm (HP:0100634) | 2.31953976 |
53 | Rapidly progressive (HP:0003678) | 2.31739856 |
54 | Rhabdomyolysis (HP:0003201) | 2.31049720 |
55 | Turricephaly (HP:0000262) | 2.30849777 |
56 | Dysostosis multiplex (HP:0000943) | 2.27398620 |
57 | Aplasia involving bones of the extremities (HP:0009825) | 2.27303791 |
58 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.27303791 |
59 | Aplasia of the phalanges of the hand (HP:0009802) | 2.27303791 |
60 | Polycythemia (HP:0001901) | 2.27033925 |
61 | Polygenic inheritance (HP:0010982) | 2.26765526 |
62 | Loss of speech (HP:0002371) | 2.26254716 |
63 | Hyperammonemia (HP:0001987) | 2.24912838 |
64 | Difficulty running (HP:0009046) | 2.24243772 |
65 | Termporal pattern (HP:0011008) | 2.23937307 |
66 | Insidious onset (HP:0003587) | 2.23937307 |
67 | Broad metatarsal (HP:0001783) | 2.23933158 |
68 | Amyloidosis (HP:0011034) | 2.21312024 |
69 | Exercise-induced muscle cramps (HP:0003710) | 2.20361735 |
70 | Respiratory distress (HP:0002098) | 2.20163513 |
71 | Foot dorsiflexor weakness (HP:0009027) | 2.19595485 |
72 | Long palpebral fissure (HP:0000637) | 2.17374980 |
73 | Recurrent abscess formation (HP:0002722) | 2.16450602 |
74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15381461 |
75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13774393 |
76 | Increased cerebral lipofuscin (HP:0011813) | 2.13745416 |
77 | Bowel incontinence (HP:0002607) | 2.13247820 |
78 | Recurrent bacterial skin infections (HP:0005406) | 2.13173053 |
79 | Onion bulb formation (HP:0003383) | 2.12110328 |
80 | Tachypnea (HP:0002789) | 2.11915824 |
81 | Metaphyseal cupping (HP:0003021) | 2.11784039 |
82 | Lower limb amyotrophy (HP:0007210) | 2.10933606 |
83 | Large for gestational age (HP:0001520) | 2.10816090 |
84 | Abnormal gallbladder morphology (HP:0012437) | 2.10575193 |
85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.09927578 |
86 | Bulbar palsy (HP:0001283) | 2.09017394 |
87 | Colitis (HP:0002583) | 2.08831612 |
88 | Gastrointestinal stroma tumor (HP:0100723) | 2.07979183 |
89 | Ventricular tachycardia (HP:0004756) | 2.06324120 |
90 | Abnormality of the salivary glands (HP:0010286) | 2.05771210 |
91 | Syncope (HP:0001279) | 2.05687990 |
92 | Ventricular fibrillation (HP:0001663) | 2.05009336 |
93 | Abnormality of glycine metabolism (HP:0010895) | 2.04291872 |
94 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.04291872 |
95 | Hypercortisolism (HP:0001578) | 2.03197620 |
96 | Ragged-red muscle fibers (HP:0003200) | 2.03045948 |
97 | Round ear (HP:0100830) | 2.02399620 |
98 | Abnormal gallbladder physiology (HP:0012438) | 2.01846907 |
99 | Cholecystitis (HP:0001082) | 2.01846907 |
100 | Right ventricular cardiomyopathy (HP:0011663) | 2.01439278 |
101 | Mesangial abnormality (HP:0001966) | 2.00507473 |
102 | Abnormality of the foot musculature (HP:0001436) | 1.99950921 |
103 | Diaphragmatic weakness (HP:0009113) | 1.99325516 |
104 | Bronchomalacia (HP:0002780) | 1.98146616 |
105 | Shallow orbits (HP:0000586) | 1.97692705 |
106 | Thin ribs (HP:0000883) | 1.97647467 |
107 | Cholelithiasis (HP:0001081) | 1.96041233 |
108 | Progressive neurologic deterioration (HP:0002344) | 1.95759822 |
109 | Abnormal large intestine physiology (HP:0012700) | 1.95529021 |
110 | EMG: myopathic abnormalities (HP:0003458) | 1.95516336 |
111 | Easy fatigability (HP:0003388) | 1.95411216 |
112 | Muscle stiffness (HP:0003552) | 1.94992490 |
113 | Hypoglycemic seizures (HP:0002173) | 1.94752328 |
114 | Atrioventricular block (HP:0001678) | 1.90220517 |
115 | Rigidity (HP:0002063) | 1.89918782 |
116 | Disproportionate tall stature (HP:0001519) | 1.88949912 |
117 | Intention tremor (HP:0002080) | 1.88516455 |
118 | Nasal polyposis (HP:0100582) | 1.88407957 |
119 | Myotonia (HP:0002486) | 1.88285403 |
120 | Persistence of primary teeth (HP:0006335) | 1.88103619 |
121 | Prolonged QT interval (HP:0001657) | 1.87508464 |
122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87428395 |
123 | Bundle branch block (HP:0011710) | 1.86929820 |
124 | Progressive external ophthalmoplegia (HP:0000590) | 1.85869089 |
125 | Hypoalphalipoproteinemia (HP:0003233) | 1.85845213 |
126 | Sensorimotor neuropathy (HP:0007141) | 1.85786016 |
127 | Clumsiness (HP:0002312) | 1.85731279 |
128 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84760545 |
129 | Broad distal phalanx of finger (HP:0009836) | 1.83413302 |
130 | Annular pancreas (HP:0001734) | 1.83205674 |
131 | Heart block (HP:0012722) | 1.82857745 |
132 | Calf muscle hypertrophy (HP:0008981) | 1.81981601 |
133 | Decreased motor nerve conduction velocity (HP:0003431) | 1.81195895 |
134 | Palpitations (HP:0001962) | 1.81180535 |
135 | Overriding aorta (HP:0002623) | 1.80406960 |
136 | Broad face (HP:0000283) | 1.80212087 |
137 | Peripheral hypomyelination (HP:0007182) | 1.79686353 |
138 | Stridor (HP:0010307) | 1.77425250 |
139 | Depression (HP:0000716) | 1.76227880 |
140 | Skin nodule (HP:0200036) | 1.76221838 |
141 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.75962804 |
142 | Subaortic stenosis (HP:0001682) | 1.75962804 |
143 | Hammertoe (HP:0001765) | 1.75673390 |
144 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75649906 |
145 | Mucopolysacchariduria (HP:0008155) | 1.75649906 |
146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74385396 |
147 | Systemic lupus erythematosus (HP:0002725) | 1.72809682 |
148 | Hypertriglyceridemia (HP:0002155) | 1.72475411 |
149 | Slow saccadic eye movements (HP:0000514) | 1.71933069 |
150 | Abnormality of complement system (HP:0005339) | 1.71751959 |
151 | Abnormal atrioventricular conduction (HP:0005150) | 1.71736891 |
152 | Hemorrhage of the eye (HP:0011885) | 1.71434425 |
153 | Abnormality of the Achilles tendon (HP:0005109) | 1.70876901 |
154 | Retinal atrophy (HP:0001105) | 1.70788162 |
155 | Germ cell neoplasia (HP:0100728) | 1.70550367 |
156 | Spinal cord lesions (HP:0100561) | 1.70104087 |
157 | Syringomyelia (HP:0003396) | 1.70104087 |
158 | Gastrointestinal inflammation (HP:0004386) | 1.67103570 |
159 | Abnormality of the calcaneus (HP:0008364) | 1.66783766 |
160 | Arnold-Chiari malformation (HP:0002308) | 1.65648708 |
161 | Increased IgE level (HP:0003212) | 1.65596953 |
162 | Truncus arteriosus (HP:0001660) | 1.65513828 |
163 | Obstructive lung disease (HP:0006536) | 1.64354233 |
164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64354233 |
165 | Hyperparathyroidism (HP:0000843) | 1.61933977 |
166 | Reticulocytosis (HP:0001923) | 1.61723331 |
167 | Vertebral compression fractures (HP:0002953) | 1.61690965 |
168 | Ulnar deviation of the wrist (HP:0003049) | 1.61250916 |
169 | Abnormality of macrophages (HP:0004311) | 1.61226269 |
170 | Hypertensive crisis (HP:0100735) | 1.60273920 |
171 | Calcaneovalgus deformity (HP:0001848) | 1.60261381 |
172 | Abnormality of the thoracic spine (HP:0100711) | 1.59292601 |
173 | Hypercalcemia (HP:0003072) | 1.59158659 |
174 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.59152245 |
175 | Pointed chin (HP:0000307) | 1.59125491 |
176 | Cerebral aneurysm (HP:0004944) | 1.58486953 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 4.50304898 |
2 | SMG1 | 4.13295708 |
3 | PRPF4B | 4.02490330 |
4 | EEF2K | 3.52193136 |
5 | TRIB3 | 3.34736057 |
6 | PHKG1 | 3.03995122 |
7 | PHKG2 | 3.03995122 |
8 | EPHB1 | 2.92807757 |
9 | RIPK4 | 2.28608778 |
10 | NTRK1 | 2.20993803 |
11 | MAP3K10 | 2.14914283 |
12 | BCKDK | 2.08970819 |
13 | CDK12 | 2.04647533 |
14 | ERN1 | 2.04430817 |
15 | TTN | 1.99142993 |
16 | KSR2 | 1.97409598 |
17 | SIK1 | 1.90674804 |
18 | MAP2K3 | 1.90476934 |
19 | LIMK1 | 1.83306060 |
20 | MAPK15 | 1.81890412 |
21 | MAP3K13 | 1.77306307 |
22 | RIPK1 | 1.75968879 |
23 | FGFR2 | 1.68263489 |
24 | PRKD3 | 1.60104890 |
25 | MAP3K2 | 1.50852828 |
26 | WNK4 | 1.47986162 |
27 | LRRK2 | 1.40469682 |
28 | STK39 | 1.40095484 |
29 | MAPKAPK5 | 1.38480322 |
30 | MAP4K1 | 1.36685598 |
31 | MAP3K9 | 1.34793239 |
32 | PKN2 | 1.31538862 |
33 | DMPK | 1.31359582 |
34 | EPHA4 | 1.27693273 |
35 | IRAK3 | 1.25753753 |
36 | PRKD1 | 1.22843977 |
37 | SGK223 | 1.21776408 |
38 | SGK494 | 1.21776408 |
39 | DAPK2 | 1.21456562 |
40 | PAK3 | 1.20502339 |
41 | MET | 1.16215258 |
42 | TESK2 | 1.15513026 |
43 | MAP2K2 | 1.15482669 |
44 | UHMK1 | 1.14796267 |
45 | TAOK2 | 1.14357491 |
46 | IRAK4 | 1.13942630 |
47 | LATS2 | 1.13907612 |
48 | ILK | 1.10211021 |
49 | MAP3K1 | 1.07169799 |
50 | PTK6 | 1.01799859 |
51 | MYLK | 1.00737501 |
52 | MTOR | 1.00587068 |
53 | PINK1 | 0.99760123 |
54 | ROCK2 | 0.99541360 |
55 | CAMK1G | 0.98190511 |
56 | DAPK3 | 0.93964407 |
57 | PAK6 | 0.93905704 |
58 | PKN1 | 0.92272468 |
59 | PTK2 | 0.91608018 |
60 | CAMK2D | 0.90995979 |
61 | RET | 0.89794567 |
62 | FER | 0.87615333 |
63 | PDPK1 | 0.87375487 |
64 | TNK2 | 0.86700776 |
65 | CAMK2G | 0.86432095 |
66 | WNK1 | 0.86152201 |
67 | BRAF | 0.84383082 |
68 | TESK1 | 0.84027100 |
69 | IRAK2 | 0.83932707 |
70 | PRKD2 | 0.83470709 |
71 | RPS6KA2 | 0.82271427 |
72 | RPS6KC1 | 0.79778236 |
73 | RPS6KL1 | 0.79778236 |
74 | MAP3K8 | 0.77776182 |
75 | TBK1 | 0.77709867 |
76 | CDK4 | 0.77428316 |
77 | MINK1 | 0.76408367 |
78 | MAPKAPK3 | 0.76327095 |
79 | TAOK3 | 0.76255275 |
80 | PRKCH | 0.76143637 |
81 | SCYL2 | 0.75928718 |
82 | ALK | 0.75788855 |
83 | ARAF | 0.75587981 |
84 | RPS6KB2 | 0.74498574 |
85 | CAMKK1 | 0.74332434 |
86 | PDGFRA | 0.73227045 |
87 | MAP2K1 | 0.72488198 |
88 | PRKG2 | 0.72474790 |
89 | MAPK7 | 0.70780281 |
90 | FGFR4 | 0.69323646 |
91 | ZAP70 | 0.68181858 |
92 | CDK6 | 0.68105306 |
93 | GRK6 | 0.66345206 |
94 | MAPK11 | 0.65482149 |
95 | TYK2 | 0.64920196 |
96 | WNK3 | 0.64853180 |
97 | MAP3K7 | 0.64568902 |
98 | TYRO3 | 0.64362923 |
99 | ROCK1 | 0.63535002 |
100 | CSK | 0.62909719 |
101 | CDK5 | 0.62750195 |
102 | CAMK2B | 0.62345153 |
103 | MAP3K14 | 0.60864285 |
104 | PIK3CG | 0.60685740 |
105 | RAF1 | 0.59823711 |
106 | MARK2 | 0.59053749 |
107 | ICK | 0.58808082 |
108 | SIK2 | 0.58243072 |
109 | NME2 | 0.58115483 |
110 | RPS6KA6 | 0.57941236 |
111 | HIPK2 | 0.57931513 |
112 | MOS | 0.57261218 |
113 | MAP3K11 | 0.56728131 |
114 | MAPK12 | 0.54739439 |
115 | OXSR1 | 0.54432496 |
116 | RPS6KA1 | 0.54282570 |
117 | MAP3K3 | 0.54075893 |
118 | BMX | 0.53828197 |
119 | FES | 0.52509592 |
120 | AKT2 | 0.51674912 |
121 | CAMKK2 | 0.51621346 |
122 | BLK | 0.51530341 |
123 | PDK4 | 0.50861201 |
124 | PDK3 | 0.50861201 |
125 | OBSCN | 0.50247934 |
126 | CDC42BPA | 0.49164214 |
127 | NTRK2 | 0.48873012 |
128 | TAOK1 | 0.48813393 |
129 | GRK5 | 0.47607473 |
130 | PIM1 | 0.47176719 |
131 | TIE1 | 0.47048515 |
132 | TGFBR2 | 0.46669321 |
133 | SGK3 | 0.46526395 |
134 | MAPK4 | 0.46284158 |
135 | STK11 | 0.45355732 |
136 | PDK1 | 0.44634018 |
137 | ERBB4 | 0.44389651 |
138 | CAMK1D | 0.43950798 |
139 | PRKACG | 0.43792818 |
140 | EPHA3 | 0.43277112 |
141 | DYRK1B | 0.43202467 |
142 | CAMK2A | 0.43108139 |
143 | YES1 | 0.41282019 |
144 | GSK3A | 0.40983351 |
145 | PRKCE | 0.40767163 |
146 | MST1R | 0.40678621 |
147 | MAPK10 | 0.39756812 |
148 | MUSK | 0.39567696 |
149 | JAK2 | 0.38272900 |
150 | MAP2K4 | 0.37656146 |
151 | HCK | 0.36651505 |
152 | PDGFRB | 0.36444582 |
153 | PIM2 | 0.36392821 |
154 | CDK7 | 0.35805950 |
155 | PAK4 | 0.35104068 |
156 | FGFR3 | 0.33970454 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.77105044 |
2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.95350055 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.76157380 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57314393 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.48462012 |
6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.43699967 |
7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.16176059 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07564677 |
9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.04136870 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00946738 |
11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.95650797 |
12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.95061094 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93257736 |
14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86114666 |
15 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.80628858 |
16 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.75271227 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73316942 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71207220 |
19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70871372 |
20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.65091534 |
21 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.64029649 |
22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61715648 |
23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.59876722 |
24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.58305426 |
25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57836274 |
26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56739963 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54105712 |
28 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52103346 |
29 | Endometrial cancer_Homo sapiens_hsa05213 | 1.51966522 |
30 | Bladder cancer_Homo sapiens_hsa05219 | 1.50683103 |
31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47561270 |
32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44503972 |
33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.43506053 |
34 | Thyroid cancer_Homo sapiens_hsa05216 | 1.42571157 |
35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41156025 |
36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40435085 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35101737 |
38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34172705 |
39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32442174 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31857731 |
41 | Bile secretion_Homo sapiens_hsa04976 | 1.30584158 |
42 | Peroxisome_Homo sapiens_hsa04146 | 1.25905439 |
43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25879283 |
44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25848436 |
45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25594244 |
46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23222472 |
47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21732421 |
48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.20822273 |
49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19306592 |
50 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.16522969 |
51 | Glioma_Homo sapiens_hsa05214 | 1.15725610 |
52 | Lysosome_Homo sapiens_hsa04142 | 1.15553818 |
53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.15085660 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14750839 |
55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.13814416 |
56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11871380 |
57 | Long-term potentiation_Homo sapiens_hsa04720 | 1.11663215 |
58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07999813 |
59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07007609 |
60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06888740 |
61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04664977 |
62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01598037 |
63 | Colorectal cancer_Homo sapiens_hsa05210 | 1.00995907 |
64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98333365 |
65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98113527 |
66 | ABC transporters_Homo sapiens_hsa02010 | 0.97418962 |
67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97348096 |
68 | Prostate cancer_Homo sapiens_hsa05215 | 0.97243103 |
69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94489482 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.93743626 |
71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92978420 |
72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92226831 |
73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91838112 |
74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91833070 |
75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91828681 |
76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91162978 |
77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90070068 |
78 | Alcoholism_Homo sapiens_hsa05034 | 0.89633479 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88718029 |
80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88696588 |
81 | Hepatitis B_Homo sapiens_hsa05161 | 0.88481687 |
82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87192433 |
83 | Apoptosis_Homo sapiens_hsa04210 | 0.87132438 |
84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86827457 |
85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85662923 |
86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84925652 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.81752535 |
88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78874014 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78451223 |
90 | Insulin secretion_Homo sapiens_hsa04911 | 0.78423995 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78257382 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78231158 |
93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77625854 |
94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76056698 |
95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75686236 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.74795867 |
97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72829382 |
98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72358064 |
99 | Tuberculosis_Homo sapiens_hsa05152 | 0.70771812 |
100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70452076 |
101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70403162 |
102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69846782 |
103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69367266 |
104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68978479 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68471000 |
106 | GABAergic synapse_Homo sapiens_hsa04727 | 0.67640846 |
107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66937942 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66617346 |
109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64811896 |
110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64761304 |
111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64721743 |
112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64364604 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63873853 |
114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63310272 |
115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61959789 |
116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60691151 |
117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60674436 |
118 | Mineral absorption_Homo sapiens_hsa04978 | 0.60171885 |
119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59850239 |
120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59166461 |
121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59138574 |
122 | Lysine degradation_Homo sapiens_hsa00310 | 0.57415224 |
123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55261482 |
124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54348559 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53248147 |
126 | Measles_Homo sapiens_hsa05162 | 0.52669772 |
127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52410899 |
128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52326160 |
129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51693733 |
130 | Amoebiasis_Homo sapiens_hsa05146 | 0.51419902 |
131 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50642386 |
132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50032945 |
133 | Salivary secretion_Homo sapiens_hsa04970 | 0.49795664 |
134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49707863 |
135 | Melanogenesis_Homo sapiens_hsa04916 | 0.49383130 |
136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48739759 |
137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47704045 |
138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47555599 |
139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47131556 |
140 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47072696 |
141 | Insulin resistance_Homo sapiens_hsa04931 | 0.46856155 |
142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46780412 |
143 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45684125 |
144 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44329409 |
145 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43431059 |
146 | Endocytosis_Homo sapiens_hsa04144 | 0.43138579 |
147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42449675 |
148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41512078 |
149 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41325565 |
150 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40706823 |
151 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40589606 |
152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39249041 |
153 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38989876 |
154 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38329022 |
155 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38158217 |
156 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38024210 |
157 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37324402 |
158 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37303712 |
159 | Tight junction_Homo sapiens_hsa04530 | 0.35498000 |
160 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35419855 |
161 | Renin secretion_Homo sapiens_hsa04924 | 0.34204157 |
162 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34181083 |
163 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33211224 |
164 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32453363 |
165 | Gap junction_Homo sapiens_hsa04540 | 0.31351996 |
166 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31307588 |
167 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31106043 |
168 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30165908 |
169 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30148153 |
170 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29601721 |